The mechanism of beta-adrenergic preconditioning: Roles for adenosine and ROS during triggering and mediation

Basic Research in Cardiology

Volumn 107, Issue 5, 2012, Pages

  Salie, Ruduwaan ^a,b   Moolman, Johannes A ^a,b   Lochner, Amanda ^a,b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Adenosine receptors; Beta adrenergic receptor preconditioning; ERK; KATP channels; Oxygen free radicals; PI3K PKB Akt

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 5 HYDROXYDECANOIC ACID; ACETYLCYSTEINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE TRIPHOSPHATASE (POTASSIUM); BISINDOLYLMALEIMIDE; BRADYKININ; DENOPAMINE; ENDORPHIN; FORMOTEROL; ICATIBANT; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NALOXONE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; WORTMANNIN; ADENOSINE; ADENOSINE RECEPTOR; BETA ADRENERGIC RECEPTOR; ETHANOLAMINE DERIVATIVE; MITOCHONDRIAL K(ATP) CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; POTASSIUM CHANNEL; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC PRECONDITIONING; BETA ADRENERGIC STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVALESCENCE; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISCHEMIC PRECONDITIONING; NONHUMAN; RAT; WESTERN BLOTTING; ANIMAL; HEART INFARCTION; HEART INFARCTION PREVENTION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOSINE; ANIMALS; ETHANOLAMINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOPROTERENOL; MYOCARDIAL INFARCTION; PHOSPHATIDYLINOSITOL 3-KINASES; POTASSIUM CHANNELS; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, PURINERGIC P1; TRIAZINES; TRIAZOLES;

EID: 84863642369     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-012-0281-5     Document Type: Article

References (82)

1. Asimakis GK, Conti VR (1995) Preconditioning with dobutamine in the isolated rat heart. Life Sci 57:177-187. doi:10.1016/0024-3205(95)00258-8
2. Asimakis GK, Inners-McBride K, Conti VR, Yang CJ (1994) Transient beta adrenergic stimulation can precondition the rat heart against post-ischemic contractile dysfunction. Cardiovasc Res 28:1726-1734. doi:10.1016/0024-3205(95) 00258-8
3. Auchampach JA, Ge ZD, Wan TC, Moore J, Gross GJ (2003) A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 285:H607-H613. doi:10.1152/ajpheart.01001.2002
4. Berne RM (1980) The role of adenosine in the regulation of coronary blood flow. Circ Res 47:807-813. doi:10.1161/01.RES. 47.6.807
5. Cohen MV, Downey JM (2008) Adenosine: trigger and mediator of cardioprotection. Basic Res Cardiol 103:203-215. doi:10.1007/ s00395-007-0687-7
6. Cohen MV, Yang X-M, Downey JM (1999) Smaller infarct does not predict extent of early functional improvement of reperfused heart. Am J Physiol 277:H1754-H1761
7. Cohen MV, Yang X-M, Liu GS, Heusch G, Downey JM (2001) Acetylcholine, bradykinin, opioids and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K (ATP) channels. Circ Res 89:273-278. doi:10.1161/hh1501.094266
8. Costa VM, Carvalho F, Bastos ML, Carvalho M, Remiao F (2011) Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart disease. Curr Med Chem 18:2272-2314
9. Cribbs JT, Strack S (2007) Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 8:839-944
10. Cronstein BN (1994) Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13
11. Davidson SM, Hausenloy D, Duchen MR, Yellon DM (2006) Signaling via the reperfusion injury kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 38:414-419. doi:10.1061/ j.biocel.2005.09.017
12. de Jong JW, de Jonge R, Keijzer E, Bradamante S (2000) The role of adenosine in preconditioning. Pharmacol Ther 87:141-149. doi:10.1016/S0163- 7258(00)00044-9
13. Deussen A, Schrader J (1991) Cardiac adenosine production is linked to myocardial pO2. J Mol Cell Cardiol 23:495-504. doi: 10.1016/0022-2828(91)90173-J
14. Dhalla NS, Adameova A, Kaur M (2010) Role of catecholamine oxidation in sudden cardiac death. Fundam Clin Pharmacol 24:539-546. doi:10.1111/j.1472-8206. 2010.00836.x
15. Di Lisa F, Kaludercic N, Carpi A, Menabo R, Giorgio M (2009) Mitochondrial pathways for ROS formation and myocardial injury: the relevance of p66Shc and monoamine oxidase. Basic Res Cardiol 104:131-139. doi:10.1007/s00395-009-0008-0014
16. Dobson JG Jr, Fenton RA, Romano FD (1987) The anti-adrenergic actions of adenosine on the heart. In: Gerlach E, Becker BF (eds) Topics and perspectives in Adenosine research. Springer-Verlag, New York, pp 356-368 doi: 10.1007/978-3-642-45619-0-29
17. Dost T, Cohen MV, Downey JM (2008) Redox signalling triggers protection during reperfusion rather than the ischemic phase. Basic Res Cardiol 103:378-384. doi:10.1007/s00395-008-0718-z
18. Downey JM, Davis AM, Cohen MV (2007) Signaling pathways in ischemic preconditioning. Heart Fail Rev 12:181-188. doi: 10.1007/s10741-007-9025-9032
19. Downey JM, Krieg T, Cohen MV (2008) Mapping preconditioning's signaling pathways: an engineering approach. Ann NY Acad Sci 1123:187-196. doi:10.1196/annals.1420.022
20. Eckle T, Krahn T, Grenz A, Köhler D, Mittelbron M, Jacobson MA, Osswald H, Thompson LF, Unerti K, Eltzschig HK (2007) Cardioprotection by ecto-50-nucleotidase (CD73) and A2B adenosine receptors. Circulation 115:1581-1590. doi:10.1161/ CURCULATIONAHA.106.669697
21. Fan WJ, van Vuuren D, Genade S, Lochner A (2010) Kinases and phosphatases in ischaemic preconditioning: a re-evaluation. Basic Res Cardiol 105:495-511. doi:10.1007/s00395-010-0086-3
22. Fenton RA, Tsimikas S, Dobson JG Jr (1990) Influence of badrenergic stimulation and contraction frequency on rat heart interstitial adenosine. Circ Res 66:457-468
23. Frances C, Nazeyrollas P, Prevost A, Moreau F, Pisani J, Davani S et al (2003) Role of beta-1 and beta-2 adrenergic adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion. J Cardiovasc Pharmacol 41:396-405. doi:10.1097/00005344-200303000-00008
24. Gross ER, Gross GJ (2006) Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70:212-221. doi: 10.1016/j.cardiores.2005. 12.019
25. Grube K, Rüdebusch J, Zhelong X, Böckenholt T et al (2011) Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes. Basic Res Cardiol 106:385-396. doi:10.1007/s00395-011-0151-6
26. Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM et al (2010) Translating novel strategies for cardioprotection: the Hatter workshop recommendations. Basic Res Cardiol 105:677-686. doi:10.1007/s00395-010-0121-4
27. Hausenloy DJ, Ong S-B, Yellon DM (2009) The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104:189-202. doi:10.1007/ s00395-009-0010-x
28. Hausenloy DJ, Tsang A, Yellon DM (2005) The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15:69-75. doi:10.1016/j.tcm.2005.03.001
29. Hausenloy DJ, Wynne AM, Yellon DM (2007) Ischemic preconditioning targets the reperfusion phase. Basic Res Cardiol 102:445-452. doi:10.1007/s00395-007- 0656-1
30. Hausenloy DJ, Yellon DM (2004) New directions for protecting the heart against ischaemia/reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61:448-460. doi:10.1016/j.cardiores.2003. 09.024
31. Headrick JP, Peart J (2005) A3 adenosine receptor-mediated protection of the ischemic heart. Vasc Pharmacol 42:271-279. doi:10.1016/j.vph.2005.02.009
32. Heusch G (2010) Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve.BasicResCardiol 105:1-5. doi:10.1007/s00395-009-0074-7
33. Heusch G (2009) No RISK, nocardioprotection? A critical perspective. Cardiovasc Res 84:173-175. doi:10.1093/cvr/cvp298
34. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118:1915-1919. doi:10.1161/CIRCULATIONAHA.108.805242
35. Heusch G, Boengler K, Schulz R (2010) Inhibition of mitochondrial permeability transition pore opening: the holy grail of cardioprotection. Basic Res Cardiol 105:151-154. doi:10.1007/ s00395-009-0080-9
36. Jenkins DP, Bugsley WB, Yellon DM (1995) Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction in stunning. J Mol Cell Cardiol 27:1623-1632. doi:10.1016/S0022-2828(95)90590-1
37. Jacobson K (1998) Adenosine A3 receptors: novel ligands and paradoxical effects. Trends Pharm Sci 19:184-194. doi:10.1016/ S0165-6147(98)01203-6
38. Jiang JL, van Rhee AM, Melman N, Ji XD, Jacobson KA (1996) 6-Phenyl-14-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 39:4667-4675. doi:10.1021/jm960457c
39. Kim Y-C, Ji XD, Melman N, Linden J, JacobsonKA(2000) Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. J Med Chem 43:1165-1172. doi:10.1021/jm990421v
40. Kuno A, Critz SD, Cui L, Solodushko V, Yang XM, Krahn T et al (2007) Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 43:262-271. doi: 10.1016/j.yjmcc.2007.05.016
41. Lankford AR, Yang JN, Rose'Meyer R, French BA, Matherne GP, Fredholm BB, Yang Z (2006) Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol 290:H1469-H1473. doi:10.1152/ajpheart.00181.2005
42. Li J, yan B, Liu Y, Xu J, Sun Y, Liang D, Peng L, Zhang Y, Zhou ZN, Shi J, Cui J, Chen YH (2010) Beta-2 but not beta-1 adrenoceptor activation modulates intracellular oxygen availability. J Physiol 588:2987-2998. doi:10.1113/jphysiol.2010.190900
43. Li YO, Fredholm BB (1985) Adenosine analogues stimulate cyclic AMP formation in rat cerebral microvessels via adenosine A2 receptors. Acta Physiol Scand 24:253-259. doi:10.1111/ j.1748-1716.1985.tb07659.x
44. Liem DA, Van den Doel MA, de Zeeuw S, Verdouw PD, Duncker DJ (2001) The role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A1 and A3 receptors. Cardiovasc Res 51:701-708. doi: 10.1016/S0008-6363(01)00321-2
45. Lochner A, Genade S, Tromp E, Podzuweit T, Moolman JA (1999) Ischemic preconditioning and the beta-adrenergic signal transduction pathway. Circulation 100:958-966
46. Lochner A, Genade S, Moolman JA (2003) Ischemic preconditioning: infarct size is a more reliable endpoint than functional recovery. Basic Res Cardiol 98:337-346. doi:10.1007/S00395-003-0427-6
47. Liu Y, Yang X, Yang XM, Förster K, Cohen MV, Krieg T, Downey JM (2010) AMP579 is revealed to be a potent A2badenosine receptor agonist in human 293 cells and rabbit hearts. Basic Res Cardiol 105:129-137. doi:10.1007/s00395- 009-0056-9
48. Maddock HL, Broadley KJ, Bril A, Khandoudi N (2001) Role of endothelium in ischaemia-induced myocardial dysfunction of isolated working hearts: cardioprotection by activation of adenosine A(2A) receptors. J Auton Pharmacol 21:263-271. doi: 10.1046/j.1365-2680.2001.00238.x
49. Maddock MM, Mocanu MM, Yellon DM (2002) Adenosine A3 receptor activation protects the myocardium from reperfusion/ reoxygenation injury. Am J Physiol 283:H1307-H1313. doi: 10.1152/ajpheart.00851.2001
50. McIntosh VJ, Lasley RD (2012) Adenosine receptor-mediated cardioprotection; are all 4 subtypes required or redundant? J Cardiovasc Pharmacol Ther 17:21-33. doi:10.1177/1074248410396877
51. Miyawaki H, Ashraf M (1997) Isoproterenol mimics calcium preconditioning-induced protection against ischemia. Am J Physiol 272:H927-H936
52. Moniri NH, Daaka Y (2007) Agonist-stimulated reactive oxygen species formation regulates beta2-adrenergic receptor signal transduction. Biochem Pharmacol 74:64-73. doi:10.1016/j.bcp.2007. 03.016
53. Morrison RR, Teng B, Oldenburg PJ, Katwa LC, Schnermann JB, Mustafa SJ (2006) Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes. Am J Physiol Heart Circ Physiol 291:H1875-H1882. doi:10.1152/ajpheart.00158.2005
54. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136. doi:10.1161/01.CIR.74.5.1124
55. Musiolik J, van Caster P, Skyschally A et al (2009) Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Cardiovasc Res 84:73-75. doi:10.1093/cvr/cvp271
56. Norton ED, Jackson EK, Turner MB et al (1992) The effect of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury. Am Heart J 123:332-338. doi:10.1016/0002-8703(92) 90643-A
57. Pain T, Yang XM, Critz SD et al (2000) Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res 87:460-466. doi:10.1161/01.RES.87.6.460
58. Palmer TM, Poucher SM, Jacobson KA, Stiles GL (1995) 125I-4-(2-7-amino-2- 2-furyl1,2,4triazolo2,3-a1,3,5 triazin-5-ylamino ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor. Mol Pharmacol 48:970-974
59. Peart JN, Headrick JP (2007) Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol Ther 114:208-221. doi:10.1016/j. pharmthera.2007.02.004
60. Peart JN, Flood A, Linden J, Matherne GP, Headrick JP (2002) Adenosine mediated cardioprotection in ischemia-reperfused mouse heart. J Cardiovasc Pharmacol 39:117-129. doi:10.1097/ 00005344-200201000-00013
61. Penna C, Mancardi D, Rastaldo R, Pagliaro P (2009) Cardioprotection: a radical view: free radicals in pre and postconditioning. Biochem Biophys Acta 1787:781-793. doi:10.1016/ j.bbabio.2009.02.008
62. Penna C, Rastaldo R, Mancardi D, Raimondo S, Cappello S, Losano S, Gattullo D, Pagliaro P (2006) Postconditioning induced cardioprotection requires signalling through a redoxsensitive mechanism, mitochondrial ATP-sensitive K? channel and protein kinase C activation. Basic Res Cardiol 101:180-189. doi:10.1007/s00395-006-0584-5
63. Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV (2006) Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res 70:308-314. doi:10.1016/j.cardiores.2006.02. 014
64. Reichelt ME, Willems L, Molina JG, Sun CX, Noble JC, Ashton KJ, Schnermann J, Blackburn MR, Headrick JP (2005) Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance. Circ Res 96:363-367. doi:10.1161/01.RES.0000156075.00127.C3
65. Robinet A, Hoizey G, Millart H (2005) PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning. Cardiovasc Res 66:530-542. doi:10.1016/j.cardiores.2005.02.010
66. Salie R, Moolman JA, Lochner A (2011) The role of the betaadrenergic receptor in the cardioprotective effects of beta-preconditioning. Cardiovasc Drugs Ther 25:31-46. doi:10.1007/ s10557-010-6275-3
67. Schulte G, Sommerschild H, Yang J, Tokuno S, Goiny M, Lövdahl C, Johansson B, Fredholm BB, Valen G (2004) Adenosine A receptors are necessary for protection of the murine heart by remote, delayed adaptation to ischaemia. Acta Physiol Scand 182:133-143. doi:10.1111/j.1365-201X.2004.01350.x
68. Schulz R, Rose J, Post H, Heusch G (1995) Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflügers Arch 430:273-280. doi:10.1007/BF00374659
69. Skyschally A, van Caster P, Boengler K et al (2008) Ischemic postconditioning in pigs: No causal role for RISK activation. Circ Res 104:15-18. doi:10.1161/CIRCRESAHA.108.186429
70. Solenkova NV, Solodushko V, Cohen MV, Downey JM (2006) Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am J Physiol Heart Circ Physiol 290:H441-H449. doi:10.1152/ajpheart.00589. 2005
71. Steinberg SF (2004) beta(2)-Adrenergic receptor signalling complexes in cardiomyocyte caveolae/lipid rafts. J Mol Cell Cardiol 37:407-415. doi:10.1016/j.yimcc.2004.04.018
72. Stenslokken KO, Rutkovskiy A, Kaljusto MJ, Hafstad AD, Larsen TS, Vaage J (2009) Inadvertent phosphorylation of survival kinases in isolated perfused hearts: a word of caution. Basic Res Cardiol 104:412-423. doi:10.1007/s00395- 009-0780-1
73. Tong H, Bernstein D, Murphy E, Steenbergen C (2005) The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J 19:983-985. doi:10.1096/fj.04-3067fje
74. Tracey WR, Magee W, Masamune H, Oleynek JJ, hill RJ (1998) Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N- methylcarboxamidoadenosine (CB-MECA) provides via KATP channel activation. Cardiovasc Res 40:138-145. doi:10.1016/S0008-6363(98)00112-6
75. Vinten-Johansen J, Thourani VH, Ronson RS, Jordan JE, Zhao ZQ, Nakamura M, Velez D, Guyton RA (1999) Broad-spectrum cardioprotection with adenosine. Ann Thorac Surg 68:1942-1948. doi:10.1016/S0003-4975(99)01018-8
76. Xi J, McIntosh R, Shen X et al (2009) Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts. J Mol Cell Cardiol 47:684-690. doi:10.1016/j.yjmcc.2009.08.009
77. Yang X, Cohen MV, Downey JM (2010) Mechanism of cardioprotection by early ischemic preconditioning. Cardiovasc Drugs Ther 24:225-234. doi:10.1007/s10557-010-6236-x
78. Yue Y, Qin Q, Cohen MV, Downey JM, Critz SD (2002) The relative order of mK(ATP) channels, free radicals and p38 MAPK in preconditioning's protective pathway in rat heart. Cardiovasc Res 55:681-689. doi:10.1016/S0008-6363(02) 00452-2
79. Ytrehus K, Liu Y, Downey JM (1994) Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266:H1145-H1152
80. Zhang GX, Kimura S, Nishiyama A, Shokoji T, Rahman M, Yao L, Nagai Y, Fujisawa Y, Miyatake A, Abe Y (2005) Cardiac oxidative stress in acute and chronic isoproterenol-infused rats. Cardiovasc Res 65:230-238. doi:10.1016/j.cardiores.2004.08.013
81. Zhang W, Yano N, Deng M, Mao Q, Shaw SK, Tseng Y-T (2011) Beta-adrenergic receptor-PI3 K signalling crosstalk in mouse heart: elucidation of immediate downstream signalling. PLoS One 6:e26581. doi:10.1371/journal.pone.0026581
82. Zhou QY, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci 89:7432-7436 http://dx.doi.org/10.1073/pnas.89.16. 7432